Takeshi Sugimoto

Summary

Affiliation: Graduate School
Country: Japan

Publications

  1. pmc Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells
    Takeshi Sugimoto
    Breast Cancer Translational Research Laboratory, The University of Texas M, d, Anderson Cancer Center, Houston, TX, USA
    Breast Cancer Res 9:R41. 2007
  2. ncbi request reprint Correlative expression of cyclooxygenase-1 (Cox-1) and human epidermal growth factor receptor type-2 (Her-2) in endometrial cancer
    Takeshi Sugimoto
    Clinical Research Division, Hyogo Medical Center for Adults, Akashi, Japan
    Kobe J Med Sci 53:177-87. 2007

Detail Information

Publications2

  1. pmc Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells
    Takeshi Sugimoto
    Breast Cancer Translational Research Laboratory, The University of Texas M, d, Anderson Cancer Center, Houston, TX, USA
    Breast Cancer Res 9:R41. 2007
    ..We hypothesized that celecoxib would enhance E1A-induced apoptosis by suppressing Bcl-2 through suppressing COX-2 expression. If successful, this strategy could represent a means of overcoming resistance to E1A gene therapy...
  2. ncbi request reprint Correlative expression of cyclooxygenase-1 (Cox-1) and human epidermal growth factor receptor type-2 (Her-2) in endometrial cancer
    Takeshi Sugimoto
    Clinical Research Division, Hyogo Medical Center for Adults, Akashi, Japan
    Kobe J Med Sci 53:177-87. 2007
    ....